Literature DB >> 17172652

Promise and pitfalls in animal-based asthma research: building a better mousetrap.

David B Corry1, Charles G Irvin.   

Abstract

Asthma is one of the leading chronic diseases in the world today. An essential component of the asthma research endeavor is the animal-based experimental disease system, which provides knowledge that is not attainable through study of patients alone. Animal research is especially valuable for elucidating pathophysiology, drug testing, and as an adjunct for interpreting the results of human clinical trials. However, controversies surrounding animal systems data and at the interface between animal and human studies raise questions regarding the true utility of experimental asthma research. We consider here the considerable promise and important limitations of animal-based systems and their prospects for the future study asthma.

Entities:  

Mesh:

Year:  2006        PMID: 17172652     DOI: 10.1385/IR:35:3:279

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  110 in total

1.  Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity.

Authors:  Omid Akbari; Gordon J Freeman; Everett H Meyer; Edward A Greenfield; Tammy T Chang; Arlene H Sharpe; Gerald Berry; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  Nat Med       Date:  2002-07-29       Impact factor: 53.440

2.  Factors associated with bronchial hyperresponsiveness in Australian adults and children.

Authors:  J K Peat; C M Salome; A J Woolcock
Journal:  Eur Respir J       Date:  1992-09       Impact factor: 16.671

3.  Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma.

Authors:  K Kumagai; I Ohno; S Okada; Y Ohkawara; K Suzuki; T Shinya; H Nagase; K Iwata; K Shirato
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

4.  Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Authors:  S A Bryan; B J O'Connor; S Matti; M J Leckie; V Kanabar; J Khan; S J Warrington; L Renzetti; A Rames; J A Bock; M J Boyce; T T Hansel; S T Holgate; P J Barnes
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

5.  Surveillance for asthma--United States, 1980-1999.

Authors:  David M Mannino; David M Homa; Lara J Akinbami; Jeanne E Moorman; Charon Gwynn; Stephen C Redd
Journal:  MMWR Surveill Summ       Date:  2002-03-29

6.  Aspergillus antigen-induced eosinophil differentiation in a murine model.

Authors:  P S Murali; G Dai; A Kumar; J N Fink; V P Kurup
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

7.  Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.

Authors:  Jonathan Corren; Thomas Casale; Yamo Deniz; Mark Ashby
Journal:  J Allergy Clin Immunol       Date:  2003-01       Impact factor: 10.793

8.  Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice.

Authors:  Andy Adler; Greg Cieslewicz; Charles G Irvin
Journal:  J Appl Physiol (1985)       Date:  2004-03-19

9.  No audible wheezing: nuggets and conundrums from mouse asthma models.

Authors:  Joshua A Boyce; K Frank Austen
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

10.  Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.

Authors:  S H Gavett; D J O'Hearn; X Li; S K Huang; F D Finkelman; M Wills-Karp
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Usefulness and optimization of mouse models of allergic airway disease.

Authors:  Fred D Finkelman; Marsha Wills-Karp
Journal:  J Allergy Clin Immunol       Date:  2008-03       Impact factor: 10.793

Review 2.  Animal models of asthma.

Authors:  Jason H T Bates; Mercedes Rincon; Charles G Irvin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-06-26       Impact factor: 5.464

3.  Abr, a negative regulator of Rac, attenuates cockroach allergen-induced asthma in a mouse model.

Authors:  Dapeng Gong; Fei Fei; Min Lim; Min Yu; John Groffen; Nora Heisterkamp
Journal:  J Immunol       Date:  2013-09-20       Impact factor: 5.422

4.  Seeking common pathophysiology in asthma, atopy and sinusitis.

Authors:  Paul C Porter; Valentine Ongeri; Amber Luong; Farrah Kheradmand; David B Corry
Journal:  Trends Immunol       Date:  2011-01-14       Impact factor: 16.687

Review 5.  Animal models of allergic airways disease: where are we and where to next?

Authors:  David G Chapman; Jane E Tully; James D Nolin; Yvonne M Janssen-Heininger; Charles G Irvin
Journal:  J Cell Biochem       Date:  2014-12       Impact factor: 4.429

Review 6.  Airway fibrinogenolysis and the initiation of allergic inflammation.

Authors:  Valentine Ongeri Millien; Wen Lu; Garbo Mak; Xiaoyi Yuan; J Morgan Knight; Paul Porter; Farrah Kheradmand; David B Corry
Journal:  Ann Am Thorac Soc       Date:  2014-12

7.  A new mechanism for inhalational priming: IL-4 bypasses innate immune signals.

Authors:  Anna M Dittrich; Hui-Chen Chen; Lan Xu; Patricia Ranney; Sean Connolly; Timur O Yarovinsky; H Kim Bottomly
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 8.  Toward a comprehensive understanding of allergic lung disease.

Authors:  David B Corry; Farrah Kheradmand
Journal:  Trans Am Clin Climatol Assoc       Date:  2009

9.  Airway Hyperresponsiveness and Inflammation: Causation, Correlation, or No Relation?

Authors:  Yvonne Mw Janssen-Heininger; Charles G Irvin; Erich V Scheller; Amy L Brown; Jay K Kolls; John F Alcorn
Journal:  J Allergy Ther       Date:  2012-01-26

Review 10.  Genetic variability of the high-affinity IgE receptor alpha-subunit (FcepsilonRIalpha).

Authors:  Daniel P Potaczek; Chiharu Nishiyama; Marek Sanak; Andrew Szczeklik; Ko Okumura
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.